Clinical Trials on CIN 2/3 in Austria

Total 835 results

Medical University of Graz

Completed

Khalifa Acute Effects

Totally Ruptured Anterior Cruciate Ligament in the Knee

Austria
Medical University of Graz
Medical University of Vienna

Unknown

Graz Osteoprotegerin as a Risk Factor (GORF) Study

Prevalent OPG and RANKL Excession in Patients With CAD

Austria
Medical University of Vienna
Medical University of Graz; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaborators

Terminated

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

Cervical Intraepithelial Neoplasia

Austria
Medical University of Vienna

Completed

ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial (ITIC)

Cervical Intraepithelial Neoplasia

Austria
Bayside Health

Completed

Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes

Type 2 Diabetes | Coronary Heart Disease

Australia
Bayside Health

Terminated

The Effect of Alcohol on ABCA1 Expression and Lipid Metabolism

Type 2 Diabetes | Heart Disease

Australia
Medical University of Vienna

Unknown

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease (RAP)

Polycystic Kidney, Type 1 Autosomal Dominant Disease | Polycystic Kidney, Type 2 Autosomal Dominant Disease

Austria
Sanofi

Terminated

Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care (RELIANCE)

Diabetes Mellitus, Type 2

Australia
Baker Heart Research Institute
National Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes...

Completed

Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes

Diabetes Mellitus, Type 2

Australia
Medical University of Vienna
Vienna Dialysis Center

Recruiting

SGLT2 Inhibition in Hemodialysis (DAPA-HD)

Diabetes Mellitus, Type 2 | Hemodialysis | Chronic Kidney Disease | Kidney Failure | Left Ventricular Hypertrophy

Austria
Novo Nordisk A/S

Completed

A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Austria, Germany, United Kingdom, Sweden, Switzerland
PX Biosolutions

Completed

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Cervical Cancer | Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Ovarian Serous Adenocarcinoma | Undifferentiated Carcinoma of Ovary | Cervical Intraepithelial Neoplasia, Grade 3

Australia
Bayside Health
The Alfred; Baker Heart and Diabetes Institute

Unknown

Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

Obesity | Cardiovascular Disease | Type 2 Diabetes

Australia
AstraZeneca

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Australia
Sanofi

Completed

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Type 2 Diabetes Mellitus

United States
Medical University of Graz

Completed

Khalifa Effectiveness Study

Total Rupture of the Anterior Cruciate Ligament in the Knee

Austria
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
MetaCure (USA), Inc.

Completed

The TANTALUS® II for the Treatment of Type 2 Diabetes (Crossover)

Diabetes Mellitus, Type 2

Austria, Germany, Italy, Poland
D3 Bio (Wuxi) Co., Ltd

Recruiting

A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors

HER-2 Positive Advanced Solid Tumors

Australia, United States, China
Martin Huelsmann

Recruiting

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Heart Diseases | Diabetes Mellitus, Type 2

New Zealand, Austria, Netherlands, Spain, United Kingdom
Klinikum Floridsdorf
Medical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum Vöcklabruck

Completed

BMI and Lymph Node Count in Colorectal Cancer

The Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long Term

Austria
Medical University Innsbruck

Unknown

Validation of Kujala German

Validation of Kujala Score German Version in Patients With Patellofemoral Instability and Scheduled MPFL-reconstruction

Austria
Memo Therapeutics AG

Completed

To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.

SARS-CoV-2 Infection

Australia
University of Adelaide
Royal Adelaide Hospital

Completed

Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air (HOTAIR4)

Insulin Resistance | Diabetes Mellitus, Type II

Australia
Medical University of Graz

Recruiting

Fecal Microbiota Transplantation in aGvHD After ASCT

Graft Versus Host Disease in GI Tract

Austria
Menzies School of Health Research

Withdrawn

Medication in Early Diabetes (MED) Study

Diabetes Mellitus, Type 2

Australia
Medical University of Vienna

Recruiting

The Effect of Hyperoxia and Hypoxia on Fluorescence Lifetime Imaging Ophthalmoscopy in Healthy Subjects- a Randomized, Double Blind, Crossover Study

To Investigate the Effect of 100% Oxygen Breathing on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Healthy Subjects

Austria
The Cleveland Clinic

Recruiting

The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial

Stage 1 Pressure Ulcer | Stage 2 Pressure Ulcer

United States, Austria
Merrimack Pharmaceuticals

Completed

A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer

HER-2 Gene Amplification

United States
GlaxoSmithKline

Terminated

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

Diabetes Mellitus, Type 2

Australia
University of Graz
Medical University of Graz

Recruiting

Maternal ExeRcIse Timing to Optimise Postprandial Glucose in Type 1 Diabetes (MERIT1D)

Type 1 Diabetes | Pregnancy in Diabetic

Austria
Everly Health

Completed

A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

SARS-CoV-2 Acute Respiratory Disease

United States
ModernaTX, Inc.

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

SARS-CoV-2

United States
Medical University Innsbruck

Completed

Argatroban in Critically Ill Patients With Heparin Resistance

Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance

Austria
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Diabetes Mellitus, Type 2 | Diabetes

Australia
Everly Health

Completed

A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19

SARS-CoV-2 Acute Respiratory Disease

United States
Pantec Biosolutions AG
Medical University of Vienna

Completed

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

Influenza in Human

Austria
Eli Lilly and Company

Completed

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8) (AWARD-8)

Type 2 Diabetes Mellitus

Argentina, United States, Mexico, Croatia, Austria, Romania, South Africa, Slovenia
Novo Nordisk A/S

Completed

Attitudes and Unmet Needs Among Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of, Mexico, India, United Kingdom, Australia, France, Saudi Arabia
Hoffmann-La Roche

Completed

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

Diabetes Mellitus Type 2

United States, Slovakia
Medical University of Vienna

Completed

Wireless US-guided CVC Placement in Infants

Central Venous Catheter | Congenital Heart Disease in Children | Wireless Ultrasound

Austria
GlaxoSmithKline

Completed

An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

A Drug Interaction Study of Albiglutide and Digoxin

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

A Drug Interaction Study of Simvastatin and Albiglutide

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects

Diabetes Mellitus, Type 2

United States
Medical University of Graz

Recruiting

Secondary Sclerosis Cholangitis Prospective (SSCpro)

Secondary Sclerosis Cholangitis in Critically Ill Patients

Austria
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Pandemic H5N1 Influenza

United States, Australia, Thailand
Eli Lilly and Company

Completed

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents (REASSURE)

Diabetes Mellitus, Type 2

Australia

Clinical Trials on CIN 2/3 in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations